Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Patient Compliance 1

Interventions

Exercise 2 Trastuzumab 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Lapatinib 1 Diet 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Patient Compliance × Acupuncture Points × Clear all

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown

Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡